An observational study in Superior Semicircular Canal Dehiscence, sponsored by University Hospital, Toulouse. Not yet recruiting. Open to participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2026-11-06.
Sponsored by University Hospital, Toulouse · Observational
Superior semicircular canal dehiscence syndrome (SSCD), also known as Minor syndrome, is a rare otoneurological condition characterized by auditory and vestibular symptoms. Emerging evidence suggests a significant psychological burden, including anxiety, depressive symptoms, and suicidal ideation, potentially related to diagnostic delay and chronic symptomatology. However, no structured epidemiological study has systematically assessed quality of life and psychological symptoms in this population.
The aim of this study is to evaluate quality of life and associated psychological symptoms in adults reporting a diagnosis of SSCD using validated self-reported questionnaires in a national cross-sectional survey.
7,201 studies on the registry are indexed under Anxiety Disorders; 1,682 are open to participants now.
This study's planned enrollment of 300 is above the median of 168 across 977 observational studies indexed under Anxiety Disorders.
Browse Anxiety Disorders studies →University Hospital, Toulouse is the lead sponsor of 807 studies on the registry; 209 are open to participants now.
Compared within Anxiety Disorders, the registry's first condition term, which may not be this study's main condition. Counted across the registry records on this site, refreshed daily. How we classify →
Patient selection was based on internal communication to members by the French association of patients with Mineur syndrome.
The study was disseminated through specialized consultations.
Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.
Exclusion Criteria:
Overall quality of life score measured using the WHOQOL-BREF questionnaire
Time frame: The inclusion day
Assessment of the prevalence of depressive symptoms in patients living with CSDS using the average score found on the Beck Depression Inventory (BDI) scale
Time frame: The inclusion day
Assessment of the prevalence of anxiety symptoms in patients living with CSDS using the mean score found on the State-Trait Anxiety Inventory (STAI-Y)
Time frame: The inclusion day
Assessment of the symptomatic intensity level of each symptom of the SDCS using an average score per item and an overall average score on the Naert questionnaire
Time frame: The inclusion day
Assessment of the impact of vestibular symptoms on the functioning of patients living with CSDS using the average score found on the Dizziness Handicap Inventory (DIH) scale
Time frame: The inclusion day
Assessment of the level of hopelessness in patients living with SDCS using the average score found on the Beck Hopelessness Scale (BHS)
Time frame: The inclusion day
To assess the difference in quality of life between adult patients who underwent surgical management of their CSSD and others using the WHOQOL-BREF score
Time frame: The inclusion day
No study locations are listed for this record.
Plan to share: Undecided
No publications or documents are linked to this record.
From the registry record's own update history. This site started tracking changes on Sep 25, 2026; for anything earlier, see the record history on ClinicalTrials.gov ↗
This study is not yet recruiting, as verified in Nov 2026. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
University Hospital, Toulouse →